QUOTE AND NEWS
Benzinga  Mar 23  Comment 
OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced that the underwriters of its previously announced public offering of common stock have exercised in full their overallotment option to purchase an additional 624,750 shares of common...
StreetInsider.com  Mar 16  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/OncoGenex+%28OGXI%29+Prices+4.17M+Offering+at+%2412Share/7275327.html for the full story.
StreetInsider.com  Mar 15  Comment 
Cogo Group (NASDAQ: COGO) 86% HIGHER; announced that its founder, CEO and Chairman, Jeffrey Kang, proposed to the Cogo Board of Directors that he purchase a series of operating entities accounting for approximately 30% of Cogo's total assets,...
StreetInsider.com  Mar 15  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/OncoGenex+Pharmaceuticals+%28OGXI%29+Commences+Common+Stock+Offering/7273480.html for the full story.
Benzinga  Mar 9  Comment 
Bloom Burton lowers its price target on BUy-rated OncoGenex Pharmaceuticals (NASDAQ: OGXI to $24 as the timing of Custirsen approval is pushed back Bloom Burton notes, "Price target decreased to $24.00 from $28.00. This is mainly due to...
StreetInsider.com  Mar 8  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Teva+Pharma+%28TEVA%29+OncoGenex+%28OGXI%29+Update+Custirsen+Phase+III/7254194.html for the full story.
StreetInsider.com  Jan 4  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/OncoGenex+%28OGXI%29+Publishes+Data+from+Custirsen+in+Advanced+NSCLC/7052913.html for the full story.
  Dec 16  Comment 
OncoGeneX announced 3q2011 earnings and held a conference call on 11/3/2011. Check out more OGXI company info and complete guide to upcoming biotech catalysts and webcasts, along with links to my notes. New feature - checked out the embedded...
  Dec 9  Comment 
2/14/2011 Webcast OGXI is focused on addressing treatment resistance in cancer Phase 3 trial of OGX-011 in NSCLC is on track to initiate in 2011 OGX-427 randomized phase 2 trial in metastatic bladder cancer will start later in 2011 Cash...
StreetInsider.com  Nov 3  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/OncoGenex+%28OGXI%29+Files+%2460M+MixedShelf/6913653.html for the full story.





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki